Oncology Practice Management Issues


March 2014, Vol 4, No 2

FDA Update

FDA News

First Drug Combination Approved for Unresectable or Metastatic Melanoma The US Food and Drug Admin­istration (FDA) approved the use of dabrafenib (Tafinlar; GlaxoSmith­Kline) plus trametinib (Mekinist; GlaxoSmithKline) as a new combination therapy for the treatment of patients with advanced melanoma [ Read More ]

New Clinical Trials Under Way

Clinical Trials Tracker

The following clinical trials are currently recruiting patients with melanoma for inclusion in several investigations. Each trial description includes the NLM Identifier to use as reference with Clinical Trials.gov. 1 Carboplatin, Paclitaxel, and Bevacizumab with or without Everolimus in Patients [ Read More ]